U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07779200) titled 'Bicarbonate HD Study' on July 02. Brief Summary: The primary goal of this single centre ob... Read More
U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07778836) titled 'A Study to Evaluate the Efficacy and Safety of Subcutaneous Nomlabofusp in Subjects With Fr... Read More
U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07780227) titled 'Laser Modification of Dental Implant Abutment Surfaces' on Aug. 19. Brief Summary: Introdu... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase I/II open label study of DJI136, a DLL3-targeted CAR-T therapy, in adult patients with ES-... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'Beamion PANTUMOR 1: A Phase II, multicentre, multicohort, open-label trial to evaluate the efficac... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'An open-label, multi-center, phase I/Ib study of IEV407 as a single agent and in combination with ... Read More
U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07779954) titled 'Nordic Sperm DNA Study' on Aug. 13. Brief Summary: Introduction The goal of this prospect... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PLOZASIRAN ... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) versus Treatment of Invest... Read More